COGENT BIOSCIENCES, INC. logo

COGENT BIOSCIENCES, INC.

23 Marks
Corp.
First Filed:Sep 13, 2023Latest Filed:Jun 16, 2026Address:180 Third Avenue, 4th Floor, Waltham, MA 02451, US

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
20(87%)
Class 42
Software, IT Services & Scientific Research
5(22%)

TTAB Proceedings

Proceedings
1
As Plaintiff
0(0%)
As Defendant
1(100%)
Extensions of Time
8

Top Firms

Loading...

Trademark Activity Timeline(20232026)

Trademark Portfolio

23 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
EKITNA (BEZUCLASTINIB) TABLETS
PENDING
Owner:
Serial:99888492
Filed:Jun 16, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITROVI (BEZUCLASTINIB) TABLETS
PENDING
Owner:
Serial:99888486
Filed:Jun 16, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
AHKITNA
AHKITNA
Trademark
Word
PENDING
Owner:
Serial:99254034
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
AKITNA
AKITNA
Trademark
Word
PENDING
Owner:
Serial:99253974
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
EKIDNA
EKIDNA
Trademark
Word
PENDING
Owner:
Serial:99254105
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
EUKITNA
EUKITNA
Trademark
Word
PENDING
Owner:
Serial:99254019
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITBY
KITBY
Trademark
Word
PENDING
Owner:
Serial:99254070
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITVAY
KITVAY
Trademark
Word
PENDING
Owner:
Serial:99254091
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITVI
KITVI
Trademark
Word
PENDING
Owner:
Serial:99254078
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITVY
KITVY
Trademark
Word
PENDING
Owner:
Serial:99254084
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
UKITNA
UKITNA
Trademark
Word
PENDING
Owner:
Serial:99253984
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
YUKITNA
YUKITNA
Trademark
Word
PENDING
Owner:
Serial:99253999
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
EKITNA
EKITNA
Trademark
Word
PENDING
Owner:
Serial:99203845
Filed:May 27, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITVOVI
KITVOVI
Trademark
Word
PENDING
Owner:
Serial:99138158
Filed:Apr 15, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITELVY
KITELVY
Trademark
Word
ABANDONED
Owner:
Serial:99135823
Filed:Apr 14, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of diseases or conditions mediated by a c-kit or mutant c-kit protein kinase
KITRELVY
KITRELVY
Trademark
Word
ABANDONED
Owner:
Serial:99135812
Filed:Apr 14, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of diseases or conditions mediated by a c-kit or mutant c-kit protein kinase
KITROVI
KITROVI
Trademark
Word
PENDING
Owner:
Serial:99135828
Filed:Apr 14, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
ZUKITNA
ZUKITNA
Trademark
Word
PENDING
Owner:
Serial:99135835
Filed:Apr 14, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
EKIDNA
EKIDNA
Service Mark
Word
ABANDONED
Owner:
Serial:98340590
Filed:Jan 3, 2024
Classes:42
Description: Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for therapeutic use, protein-based toxins for therapeutic use, protein-based toxins generated in an in vitro cell-free expression system for therapeutic and medical research uses; Research and development in the field of bioinformatics and production of protein-based toxins having therapeutic applications; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development of new toxin compounds for therapeutic use, namely, new protein-based toxins for therapeutic use; Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for diagnostic use, protein-based toxins for diagnostic use, protein-based toxins generated in an in vitro cell-free expression system for diagnostic and medical research uses
COGENT BIOSCIENCES
COGENT BIOSCIENCES
Trademark
Word
PENDING
Owner:
Serial:98178294
Filed:Sep 13, 2023
Classes:5, 42
Description: Pharmaceutical preparations in the fields of oncology, rare diseases, and genetically defined diseases; "BIOSCIENCES"; Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials
COGENT BIOSCIENCES
COGENT BIOSCIENCES
Service Mark
Word
PENDING
Owner:
Serial:98178242
Filed:Sep 13, 2023
Classes:42
Description: "BIOSCIENCES"; Development of pharmaceutical preparations and medicines; Scientific research and development; Pharmaceutical research and development services; Clinical research for others in the fields of oncology, rare diseases, and genetically defined diseases; Medical and scientific research, namely, conducting clinical trials for others
COGENT BIOSCIENCES
COGENT BIOSCIENCES
Service Mark
Combined
PENDING
Owner:
Serial:98178287
Filed:Sep 13, 2023
Classes:42
Description: "BIOSCIENCES"; Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials
COGENT BIOSCIENCES
COGENT BIOSCIENCES
Trademark
Combined
PENDING
Owner:
Serial:98178274
Filed:Sep 13, 2023
Classes:5, 42
Description: Pharmaceutical preparations in the fields of oncology, rare diseases, and genetically defined diseases; "BIOSCIENCES"; Development of pharmaceutical preparations and medicines; Scientific research and development; Pharmaceutical research and development services; Clinical research for others in the fields of oncology, rare diseases, and genetically defined diseases; Medical and scientific research, namely, conducting clinical trials for others